 endovascular therapy
will become increasingly clear. The scheme would need

to correlate with outcomes and not practice patterns. We
envision that clinical decision making and outcomes
comparisons between alternative treatments would be facilitated by deﬁning subgroups of patients across three
distinct coordinatesdlimb severity (SVS WIfI), patient
risk (comorbidity index), and anatomic severity. Such
a properly stratiﬁed, three-dimensional matrix would lead
to improved clinical